Indications And Rationale For High-Dose-Rate Interstitial Brachytherapy In The Management of Carcinoma Cervix and Other Gynaecologic Malignancies

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 11

Abstract

Objective:To report indications, rationale and technique of high-dose-rate (HDR) interstitial brachytherapy in the treatment of cervical carcinoma and other gynaecologic malignancies. Materials and Methods:Between 2014 and 2017, 45 patients (35 - cervical carcinoma, 8 –Ca vaginal vault, 1 – Ca cervical stump and 1 – Ca vagina) were treated with interstitial implant. Patient characteristics, implant technique, and indications were reported. Results:All patients completed EBRT prior to brachytherapy and underwent an interstitial implant using a MUPIT applicator. Clinical and imaging findings prior to EBRT and brachytherapy were used to estimate tumour volume and number of needles required for implantation. 71% of patients received external beam RT to a dose of 50Gy in 25 fractions. 38 patients received concurrent cisplatin along with radiotherapy. ISBT dose ranged from 8Gy to 22.5Gy. The indications for interstitial brachytherapy for patients in our study are bulky parametrial disease (n = 27), extensive vaginal extension (n = 11), bulky primary disease (n= 10), recurrent disease post hysterectomy (n = 8), adjacent organ invasion (n = 7), presence of fistula (n = 4), obliteration of cervical os (n = 4), recurrent disease after pelvic RT (n = 2) and Carcinoma cervical stump (n = 1). Conclusion:Interstitial implant can be a feasible treatment option in patients with gynaecologic malignancies who have limitations with standard intracavitary insertion. The case selection for interstitial brachytherapy should be done judiciously

Authors and Affiliations

Dr. George John, Dr. Hasib A. G, Mr. Sridhar C. H, Dr. M. S Athiyamaan, Dr. Sandesh Rao, Dr. Sharaschandra Shankar, Dr. Pavan Kumar Reddy, Dr. Priyanka Augustine

Keywords

Related Articles

FamilialHypercholesterolemia: Screening, Diagnosis And Management of Patients.

Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism resulting in elevated serum low – density lipoprotein cholesterol leading to increased risk for premature cardiovascular disease (CVD). T...

Malignant Mixed Mullerian Tumor of Uterine Corpus: A Rare Case Report.

Carcinosarcomas which is also known as Malignant Mixed Mullerian tumor are rare high grade neoplasms.It accounts to about 2-5% of the tumors arising from the body of uterus.Generally occuring in the post menopausal women...

Rationale and application of Nasolabial flap in the Management of Oral Submucous Fibrosis-A Case Series

Oral submucous fibrosis is an insidious chronic debilitating disease affecting the oral cavity, pharynx, and upper digestive tract and associated with restricted mouth opening. Its etiology is directly linked to betel nu...

Impact of Late Laparoscopic Cholecystectomy beyond 72 Hours and Less Than 6 Weeks for Acute Cholecystitis on Patient’squality of Life.ArandomizedControl Trial.

Background. Early and delayed laparoscopic cholecystectomy is well established, but the role of late laparoscopic cholecystectomy is not well documented. Aim.To evaluate the role of late laparoscopic cholecystectomy in w...

A Comparative Study of Epidural, Bupivacaine with Butorphanol and Bupivacaine with Fentanyl In Lower Limb Surgeries

Introduction: Intrathecal anesthesia and epidural anesthesia (EA) are the most popular regional anesthesia techniques used for surgeries below umbilicus. EA is more versatile in providing anesthesia, analgesia and treatm...

Download PDF file
  • EP ID EP249529
  • DOI 10.9790/0853-1611102328
  • Views 54
  • Downloads 0

How To Cite

Dr. George John, Dr. Hasib A. G, Mr. Sridhar C. H, Dr. M. S Athiyamaan, Dr. Sandesh Rao, Dr. Sharaschandra Shankar, Dr. Pavan Kumar Reddy, Dr. Priyanka Augustine (2017). Indications And Rationale For High-Dose-Rate Interstitial Brachytherapy In The Management of Carcinoma Cervix and Other Gynaecologic Malignancies. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(11), 23-28. https://europub.co.uk./articles/-A-249529